Gibbs Wealth Management »

Tg Therapeutics shares owned by Gibbs Wealth Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Gibbs Wealth Management from 13F filings

Historical chart of Gibbs Wealth Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Gibbs Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Gibbs Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $455k 16k 28.47

More positions owned by Gibbs Wealth Management

Spdr Series Trust State Street Spd (SPYG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Spdr Series Trust State Street Spd (SPYV)
Spdr Series Trust State Street Spd (SPMB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust State Street Spd (SPTL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr Series Trust State Street Spd (BIL)
Eli Lilly & Co. (LLY)
Spdr Series Trust State Street Spd (SPSM)

View all positions for Gibbs Wealth Management

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
ClearBridge Advisors
Soleus Capital Management
Geode Capital Management
Susquehanna International
Congress Asset Management
Jane Street
Citadel Advisors
Pictet Asset Management Holding SA
Hood River Capital Management
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Tg Therapeutics